The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide

被引:1
作者
Yang, Geliang [1 ,2 ]
Li, Min [1 ]
Zhang, Huiqing [3 ]
Yang, Yufei [4 ]
机构
[1] Shanghai Clin Res Ctr, Dept Med, Shanghai, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Dept Tradit Chinese Med, Beijing, Peoples R China
[3] Naval Med Univ, Dept Tradit Chinese Med, Shanghai 200433, Peoples R China
[4] China Acad Chinese Med Sci, Xiyuan Hosp, Dept Oncol Diag & Treatment, Beijing 100091, Peoples R China
关键词
D O I
10.1177/1534735421991218
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 5 条
  • [1] Integrative Cancer Therapies: Learning From COVID-19
    Block, Keith I.
    [J]. INTEGRATIVE CANCER THERAPIES, 2020, 19
  • [2] Narayanan S., 2020, GLOB ADV HLTH MED, V9
  • [3] Cancer patient management strategy in a Cancer Center of Zhejiang, China during the COVID-19 pandemic
    Xu, Songxiao
    Cheng, Xiangdong
    Pan, Zhiwen
    Song, Qian
    Wang, Yihong
    Xiong, Juan
    Chen, Yongyi
    Fan, Fan
    Zhu, Jing
    Wu, Wanying
    Deng, Xueying
    Yu, Yanpin
    Xu, Xiaohong
    Chen, Wenhu
    Zhu, Tao
    Yu, Yang
    Liu, Kaizhong
    Shao, Guoliang
    Chen, Ming
    Yu, Enyan
    [J]. BMC CANCER, 2020, 20 (01)
  • [4] Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19
    Yang, Geliang
    Zhang, Huiqing
    Yang, Yufei
    [J]. INTEGRATIVE CANCER THERAPIES, 2020, 19
  • [5] Characteristic Analysis of Complementary and Alternative Medicine in Randomized Controlled Trials of Oncology: A Comparison of Published Studies
    Zhang, Huiqing
    Yang, Geliang
    Zhang, Wei
    Gu, Wei
    Su, Yonghua
    Ling, Changquan
    [J]. INTEGRATIVE CANCER THERAPIES, 2018, 17 (02) : 551 - 557